About
Applied Cognition develops non-invasive technology and drugs to measure and enhance glymphatic system function, targeting neurodegenerative diseases such as Alzheimer's and Parkinson's.
Explore APPLIED COGNITION's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.